# Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults

> **NCT07717710** · EARLY_PHASE1 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Adult

## Interventions

- **DRUG:** Ivabradine (single oral dose)

## Key facts

- **NCT ID:** NCT07717710
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717710, "Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07717710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*